 | • レポートコード：20QY06-02580 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ナノ医薬品のグローバル市場について種類別（リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルションとナノエマルション、ナノサスペンション）、用途別（癌および腫瘍、自己免疫疾患、炎症、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ナノ医薬品市場の概要 ・世界の主要地域別ナノ医薬品市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のナノ医薬品市場規模2015-2026：種類別（リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルションとナノエマルション、ナノサスペンション） ・世界のナノ医薬品市場規模2015-2026：用途別（癌および腫瘍、自己免疫疾患、炎症、その他） ・ナノ医薬品の北米市場規模2015-2020 ・ナノ医薬品のヨーロッパ市場規模2015-2020 ・ナノ医薬品の中国市場規模2015-2020 ・ナノ医薬品の日本市場規模2015-2020 ・ナノ医薬品の東南アジア市場規模2015-2020 ・ナノ医薬品のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Merck、Pfizer、Novartis、Abbott、GlaxoSmithKline、Roche、Sanofi、Eli Lilly、Astrazeneca、Johnson & Johnson、Celgene、Novavax、Stryker、Gilead Sciences、OSI Pharmaceuticals、Kadmon Pharmaceuticals、Samyang Biopharm、Mitsubishi Pharma、Kaken Pharmaceutical、Selecta Biosciences、Par Pharmaceutical、Cerulean Pharma、Navidea Biopharmaceuticals、Lummy） ・ナノ医薬品の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ナノ医薬品の市場動向・機会・課題 ・調査の結論 |
Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their “bulk” counterparts primarily because of size.
There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier.
Market Analysis and Insights: Global Nanopharmaceuticals Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Nanopharmaceuticals market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Nanopharmaceuticals industry.
Based on our recent survey, we have several different scenarios about the Nanopharmaceuticals YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 24020 million in 2019. The market size of Nanopharmaceuticals will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Nanopharmaceuticals Scope and Market Size
The global Nanopharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nanopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Nanopharmaceuticals market is segmented into
Liposomes
Polymeric Micelles
Solid Lipid Nanoparticles
Microemulsion and Nnanoemulsion
Nanosuspension
Segment by Application, the Nanopharmaceuticals market is segmented into
Cancer and Tumor
Autoimmune Disorders
Inflammation
Others
The Nanopharmaceuticals market is analysed and market size information is provided by regions (countries). Segment by Application, the Nanopharmaceuticals market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Nanopharmaceuticals Market Share Analysis
Nanopharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nanopharmaceuticals business, the date to enter into the Nanopharmaceuticals market, Nanopharmaceuticals product introduction, recent developments, etc.
The major vendors covered:
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy
1 Nanopharmaceuticals Market Overview
1.1 Nanopharmaceuticals Product Scope
1.2 Nanopharmaceuticals Segment by Type
1.2.1 Global Nanopharmaceuticals Sales by Type (2020-2026)
1.2.2 Liposomes
1.2.3 Polymeric Micelles
1.2.4 Solid Lipid Nanoparticles
1.2.5 Microemulsion and Nnanoemulsion
1.2.6 Nanosuspension
1.3 Nanopharmaceuticals Segment by Application
1.3.1 Global Nanopharmaceuticals Sales Comparison by Application (2020-2026)
1.3.2 Cancer and Tumor
1.3.3 Autoimmune Disorders
1.3.4 Inflammation
1.3.5 Others
1.4 Nanopharmaceuticals Market Estimates and Forecasts (2015-2026)
1.4.1 Global Nanopharmaceuticals Sales Growth Rate (2015-2026)
1.4.2 Global Nanopharmaceuticals Revenue and Growth Rate (2015-2026)
1.4.3 Global Nanopharmaceuticals Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Nanopharmaceuticals Industry Impact
1.5.1 How the Covid-19 is Affecting the Nanopharmaceuticals Industry
1.5.1.1 Nanopharmaceuticals Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Nanopharmaceuticals Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Nanopharmaceuticals Players to Combat Covid-19 Impact
2 Nanopharmaceuticals Estimate and Forecast by Region
2.1 Global Nanopharmaceuticals Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Nanopharmaceuticals Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Nanopharmaceuticals Sales Market Share by Region (2015-2020)
2.2.2 Global Nanopharmaceuticals Revenue Market Share by Region (2015-2020)
2.3 Global Nanopharmaceuticals Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Nanopharmaceuticals Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Nanopharmaceuticals Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Nanopharmaceuticals Estimates and Projections (2015-2026)
2.4.2 Europe Nanopharmaceuticals Estimates and Projections (2015-2026)
2.4.3 China Nanopharmaceuticals Estimates and Projections (2015-2026)
2.4.4 Japan Nanopharmaceuticals Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Nanopharmaceuticals Estimates and Projections (2015-2026)
2.4.6 India Nanopharmaceuticals Estimates and Projections (2015-2026)
3 Global Nanopharmaceuticals Competition Landscape by Players
3.1 Global Top Nanopharmaceuticals Players by Sales (2015-2020)
3.2 Global Top Nanopharmaceuticals Players by Revenue (2015-2020)
3.3 Global Nanopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanopharmaceuticals as of 2019)
3.4 Global Nanopharmaceuticals Average Price by Company (2015-2020)
3.5 Manufacturers Nanopharmaceuticals Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Nanopharmaceuticals Players (Opinion Leaders)
4 Global Nanopharmaceuticals Market Size by Type
4.1 Global Nanopharmaceuticals Historic Market Review by Type (2015-2020)
4.1.1 Global Nanopharmaceuticals Sales Market Share by Type (2015-2020)
4.1.2 Global Nanopharmaceuticals Revenue Market Share by Type (2015-2020)
4.1.3 Global Nanopharmaceuticals Price by Type (2014-2020)
4.2 Global Nanopharmaceuticals Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Nanopharmaceuticals Sales Forecast by Type (2021-2026)
4.2.2 Global Nanopharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.3 Global Nanopharmaceuticals Price Forecast by Type (2021-2026)
5 Global Nanopharmaceuticals Market Size by Application
5.1 Global Nanopharmaceuticals Historic Market Review by Application (2015-2020)
5.1.1 Global Nanopharmaceuticals Sales Market Share by Application (2015-2020)
5.1.2 Global Nanopharmaceuticals Revenue Market Share by Application (2015-2020)
5.1.3 Global Nanopharmaceuticals Price by Application (2015-2020)
5.2 Global Nanopharmaceuticals Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Nanopharmaceuticals Sales Forecast by Application (2021-2026)
5.2.2 Global Nanopharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.3 Global Nanopharmaceuticals Price Forecast by Application (2021-2026)
3 North America Nanopharmaceuticals Market Facts & Figures
3.2 North America Nanopharmaceuticals Sales Market Share by Company (2015-2020)
3.3 North America Nanopharmaceuticals Sales Market Share by Type (2015-2020)
3.4 North America Nanopharmaceuticals Sales Market Share by Application (2015-2020)
4 Europe Nanopharmaceuticals Market Facts & Figures
4.2 Europe Nanopharmaceuticals Sales Market Share by Company (2015-2020)
4.3 Europe Nanopharmaceuticals Sales Market Share by Type (2015-2020)
4.4 Europe Nanopharmaceuticals Sales Market Share by Application (2015-2020)
5 China Nanopharmaceuticals Market Facts & Figures
5.2 China Nanopharmaceuticals Sales Market Share by Company (2015-2020)
5.3 China Nanopharmaceuticals Sales Market Share by Type (2015-2020)
5.4 China Nanopharmaceuticals Sales Market Share by Application (2015-2020)
6 Japan Nanopharmaceuticals Market Facts & Figures
6.2 Japan Nanopharmaceuticals Sales Market Share by Company (2015-2020)
6.3 Japan Nanopharmaceuticals Sales Market Share by Type (2015-2020)
6.4 Japan Nanopharmaceuticals Sales Market Share by Application (2015-2020)
7 Southeast Asia Nanopharmaceuticals Market Facts & Figures
7.2 Southeast Asia Nanopharmaceuticals Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Nanopharmaceuticals Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Nanopharmaceuticals Sales Market Share by Application (2015-2020)
8 India Nanopharmaceuticals Market Facts & Figures
8.2 India Nanopharmaceuticals Sales Market Share by Company (2015-2020)
8.3 India Nanopharmaceuticals Sales Market Share by Type (2015-2020)
8.4 India Nanopharmaceuticals Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Nanopharmaceuticals Business
12.1 Merck
12.1.1 Merck Nanopharmaceuticals Corporation Information
12.1.2 Merck Nanopharmaceuticals Business Overview and Total Revenue
12.1.3 Merck Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck Nanopharmaceuticals Products Offered
12.1.5 Merck Recent Development
12.2 Pfizer
12.2.1 Pfizer Nanopharmaceuticals Corporation Information
12.2.2 Pfizer Nanopharmaceuticals Business Overview and Total Revenue
12.2.3 Pfizer Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Nanopharmaceuticals Products Offered
12.2.5 Pfizer Recent Development
12.3 Novartis
12.3.1 Novartis Nanopharmaceuticals Corporation Information
12.3.2 Novartis Nanopharmaceuticals Business Overview and Total Revenue
12.3.3 Novartis Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Nanopharmaceuticals Products Offered
12.3.5 Novartis Recent Development
12.4 Abbott
12.4.1 Abbott Nanopharmaceuticals Corporation Information
12.4.2 Abbott Nanopharmaceuticals Business Overview and Total Revenue
12.4.3 Abbott Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Abbott Nanopharmaceuticals Products Offered
12.4.5 Abbott Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Nanopharmaceuticals Corporation Information
12.5.2 GlaxoSmithKline Nanopharmaceuticals Business Overview and Total Revenue
12.5.3 GlaxoSmithKline Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GlaxoSmithKline Nanopharmaceuticals Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 Roche
12.6.1 Roche Nanopharmaceuticals Corporation Information
12.6.2 Roche Nanopharmaceuticals Business Overview and Total Revenue
12.6.3 Roche Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Roche Nanopharmaceuticals Products Offered
12.6.5 Roche Recent Development
12.7 Sanofi
12.7.1 Sanofi Nanopharmaceuticals Corporation Information
12.7.2 Sanofi Nanopharmaceuticals Business Overview and Total Revenue
12.7.3 Sanofi Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sanofi Nanopharmaceuticals Products Offered
12.7.5 Sanofi Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Nanopharmaceuticals Corporation Information
12.8.2 Eli Lilly Nanopharmaceuticals Business Overview and Total Revenue
12.8.3 Eli Lilly Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Eli Lilly Nanopharmaceuticals Products Offered
12.8.5 Eli Lilly Recent Development
12.9 Astrazeneca
12.9.1 Astrazeneca Nanopharmaceuticals Corporation Information
12.9.2 Astrazeneca Nanopharmaceuticals Business Overview and Total Revenue
12.9.3 Astrazeneca Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Astrazeneca Nanopharmaceuticals Products Offered
12.9.5 Astrazeneca Recent Development
12.10 Johnson & Johnson
12.10.1 Johnson & Johnson Nanopharmaceuticals Corporation Information
12.10.2 Johnson & Johnson Nanopharmaceuticals Business Overview and Total Revenue
12.10.3 Johnson & Johnson Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Johnson & Johnson Nanopharmaceuticals Products Offered
12.10.5 Johnson & Johnson Recent Development
12.11 Celgene
12.11.1 Celgene Nanopharmaceuticals Corporation Information
12.11.2 Celgene Nanopharmaceuticals Business Overview and Total Revenue
12.11.3 Celgene Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Celgene Nanopharmaceuticals Products Offered
12.11.5 Celgene Recent Development
12.12 Novavax
12.12.1 Novavax Nanopharmaceuticals Corporation Information
12.12.2 Novavax Nanopharmaceuticals Business Overview and Total Revenue
12.12.3 Novavax Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Novavax Nanopharmaceuticals Products Offered
12.12.5 Novavax Recent Development
12.13 Stryker
12.13.1 Stryker Nanopharmaceuticals Corporation Information
12.13.2 Stryker Nanopharmaceuticals Business Overview and Total Revenue
12.13.3 Stryker Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Stryker Nanopharmaceuticals Products Offered
12.13.5 Stryker Recent Development
12.14 Gilead Sciences
12.14.1 Gilead Sciences Nanopharmaceuticals Corporation Information
12.14.2 Gilead Sciences Nanopharmaceuticals Business Overview and Total Revenue
12.14.3 Gilead Sciences Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Gilead Sciences Nanopharmaceuticals Products Offered
12.14.5 Gilead Sciences Recent Development
12.15 OSI Pharmaceuticals
12.15.1 OSI Pharmaceuticals Nanopharmaceuticals Corporation Information
12.15.2 OSI Pharmaceuticals Nanopharmaceuticals Business Overview and Total Revenue
12.15.3 OSI Pharmaceuticals Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.15.4 OSI Pharmaceuticals Nanopharmaceuticals Products Offered
12.15.5 OSI Pharmaceuticals Recent Development
12.16 Kadmon Pharmaceuticals
12.16.1 Kadmon Pharmaceuticals Nanopharmaceuticals Corporation Information
12.16.2 Kadmon Pharmaceuticals Nanopharmaceuticals Business Overview and Total Revenue
12.16.3 Kadmon Pharmaceuticals Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Kadmon Pharmaceuticals Nanopharmaceuticals Products Offered
12.16.5 Kadmon Pharmaceuticals Recent Development
12.17 Samyang Biopharm
12.17.1 Samyang Biopharm Nanopharmaceuticals Corporation Information
12.17.2 Samyang Biopharm Nanopharmaceuticals Business Overview and Total Revenue
12.17.3 Samyang Biopharm Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Samyang Biopharm Nanopharmaceuticals Products Offered
12.17.5 Samyang Biopharm Recent Development
12.18 Mitsubishi Pharma
12.18.1 Mitsubishi Pharma Nanopharmaceuticals Corporation Information
12.18.2 Mitsubishi Pharma Nanopharmaceuticals Business Overview and Total Revenue
12.18.3 Mitsubishi Pharma Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Mitsubishi Pharma Nanopharmaceuticals Products Offered
12.18.5 Mitsubishi Pharma Recent Development
12.19 Kaken Pharmaceutical
12.19.1 Kaken Pharmaceutical Nanopharmaceuticals Corporation Information
12.19.2 Kaken Pharmaceutical Nanopharmaceuticals Business Overview and Total Revenue
12.19.3 Kaken Pharmaceutical Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Kaken Pharmaceutical Nanopharmaceuticals Products Offered
12.19.5 Kaken Pharmaceutical Recent Development
12.20 Selecta Biosciences
12.20.1 Selecta Biosciences Nanopharmaceuticals Corporation Information
12.20.2 Selecta Biosciences Nanopharmaceuticals Business Overview and Total Revenue
12.20.3 Selecta Biosciences Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Selecta Biosciences Nanopharmaceuticals Products Offered
12.20.5 Selecta Biosciences Recent Development
12.21 Par Pharmaceutical
12.21.1 Par Pharmaceutical Nanopharmaceuticals Corporation Information
12.21.2 Par Pharmaceutical Nanopharmaceuticals Business Overview and Total Revenue
12.21.3 Par Pharmaceutical Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Par Pharmaceutical Nanopharmaceuticals Products Offered
12.21.5 Par Pharmaceutical Recent Development
12.22 Cerulean Pharma
12.22.1 Cerulean Pharma Nanopharmaceuticals Corporation Information
12.22.2 Cerulean Pharma Nanopharmaceuticals Business Overview and Total Revenue
12.22.3 Cerulean Pharma Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Cerulean Pharma Nanopharmaceuticals Products Offered
12.22.5 Cerulean Pharma Recent Development
12.23 Navidea Biopharmaceuticals
12.23.1 Navidea Biopharmaceuticals Nanopharmaceuticals Corporation Information
12.23.2 Navidea Biopharmaceuticals Nanopharmaceuticals Business Overview and Total Revenue
12.23.3 Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.23.4 Navidea Biopharmaceuticals Nanopharmaceuticals Products Offered
12.23.5 Navidea Biopharmaceuticals Recent Development
12.24 Lummy
12.24.1 Lummy Nanopharmaceuticals Corporation Information
12.24.2 Lummy Nanopharmaceuticals Business Overview and Total Revenue
12.24.3 Lummy Nanopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.24.4 Lummy Nanopharmaceuticals Products Offered
12.24.5 Lummy Recent Development
13 Nanopharmaceuticals Manufacturing Cost Analysis
13.1 Nanopharmaceuticals Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Nanopharmaceuticals
13.4 Nanopharmaceuticals Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Nanopharmaceuticals Distributors List
14.3 Nanopharmaceuticals Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Nanopharmaceuticals Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Nanopharmaceuticals Sales (K MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Nanopharmaceuticals Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Nanopharmaceuticals Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Nanopharmaceuticals Players to Combat Covid-19 Impact
Table 8. Global Market Nanopharmaceuticals Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Nanopharmaceuticals Sales (K MT) by Region (2015-2020)
Table 10. Global Nanopharmaceuticals Sales Market Share by Region (2015-2020)
Table 11. Global Nanopharmaceuticals Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Nanopharmaceuticals Revenue Share by Region (2015-2020)
Table 13. Global Nanopharmaceuticals Sales (K MT) Forecast by Region (2021-2026)
Table 14. Global Nanopharmaceuticals Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Nanopharmaceuticals Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Nanopharmaceuticals Revenue Share Forecast by Region (2021-2026)
Table 17. Global Nanopharmaceuticals (K MT) of Key Companies (2015-2020)
Table 18. Global Nanopharmaceuticals Sales Share by Company (2015-2020)
Table 19. Global Nanopharmaceuticals Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Nanopharmaceuticals Revenue Share by Company (2015-2020)
Table 21. Global Nanopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanopharmaceuticals as of 2019)
Table 22. Global Nanopharmaceuticals Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Nanopharmaceuticals Manufacturing Sites and Area Served
Table 24. Manufacturers Nanopharmaceuticals Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Nanopharmaceuticals Players
Table 27. Global Nanopharmaceuticals Sales (K MT) by Type (2015-2020)
Table 28. Global Nanopharmaceuticals Sales Share by Type (2015-2020)
Table 29. Global Nanopharmaceuticals Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Nanopharmaceuticals Price (K MT) by Type (2015-2020)
Table 31. Global Nanopharmaceuticals Sales Share by Type (2021-2026)
Table 32. Global Nanopharmaceuticals Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Nanopharmaceuticals Revenue Share by Type (2021-2026)
Table 34. Global Nanopharmaceuticals Price (K MT) by Type (2021-2026)
Table 35. Global Nanopharmaceuticals Sales (K MT) by Application (2015-2020)
Table 36. Global Nanopharmaceuticals Sales Share by Application (2015-2020)
Table 37. Global Nanopharmaceuticals Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Nanopharmaceuticals Price (K MT) by Application (2015-2020)
Table 39. Global Nanopharmaceuticals Sales (K MT) by Application (2021-2026)
Table 40. Global Nanopharmaceuticals Sales Share by Application (2021-2026)
Table 41. Global Nanopharmaceuticals Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Nanopharmaceuticals Revenue Share by Application (2021-2026)
Table 43. Global Nanopharmaceuticals Price (K MT) by Application (2021-2026)
Table 44. United States Nanopharmaceuticals Sales (K MT) by Company (2015-2020)
Table 45. United States Nanopharmaceuticals Sales Market Share by Company (2015-2020)
Table 46. United States Nanopharmaceuticals Sales (K MT) by Type (2015-2020)
Table 47. United States Nanopharmaceuticals Sales Market Share by Type (2015-2020)
Table 48. United States Nanopharmaceuticals Sales (K MT) by Application (2015-2020)
Table 49. United States Nanopharmaceuticals Sales Market Share by Application (2015-2020)
Table 50. Europe Nanopharmaceuticals Sales (K MT) by Company (2015-2020)
Table 51. Europe Nanopharmaceuticals Sales Market Share by Company (2015-2020)
Table 52. Europe Nanopharmaceuticals Sales (K MT) by Type (2015-2020)
Table 53. Europe Nanopharmaceuticals Sales Market Share by Type (2015-2020)
Table 54. Europe Nanopharmaceuticals Sales (K MT) by Application (2015-2020)
Table 55. Europe Nanopharmaceuticals Sales Market Share by Type (2015-2020)
Table 56. China Nanopharmaceuticals Sales (K MT) by Company (2015-2020)
Table 57. China Nanopharmaceuticals Sales Market Share by Company (2015-2020)
Table 58. China Nanopharmaceuticals Sales (K MT) by Type (2015-2020)
Table 59. China Nanopharmaceuticals Sales Market Share by Type (2015-2020)
Table 60. China Nanopharmaceuticals Sales (K MT) by Application (2015-2020)
Table 61. China Nanopharmaceuticals Sales Market Share by Application (2015-2020)
Table 62. Japan Nanopharmaceuticals Sales (K MT) by Company (2015-2020)
Table 63. Japan Nanopharmaceuticals Sales Market Share by Company (2015-2020)
Table 64. Japan Nanopharmaceuticals Sales (K MT) by Type (2015-2020)
Table 65. Japan Nanopharmaceuticals Sales Market Share by Type (2015-2020)
Table 66. Japan Nanopharmaceuticals Sales (K MT) by Application (2015-2020)
Table 67. Japan Nanopharmaceuticals Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Nanopharmaceuticals Sales (K MT) by Company (2015-2020)
Table 69. Southeast Asia Nanopharmaceuticals Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Nanopharmaceuticals Sales (K MT) by Type (2015-2020)
Table 71. Southeast Asia Nanopharmaceuticals Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Nanopharmaceuticals Sales (K MT) by Type (2015-2020)
Table 73. Southeast Asia Nanopharmaceuticals Sales Market Share by Application (2015-2020)
Table 74. India Nanopharmaceuticals Sales (K MT) by Company (2015-2020)
Table 75. India Nanopharmaceuticals Sales Market Share by Company (2015-2020)
Table 76. India Nanopharmaceuticals Sales (K MT) by Type (2015-2020)
Table 77. India Nanopharmaceuticals Sales Market Share by Type (2015-2020)
Table 78. India Nanopharmaceuticals Sales (K MT) by Application (2015-2020)
Table 79. India Nanopharmaceuticals Sales Market Share by Application (2015-2020)
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Merck Nanopharmaceuticals Product
Table 84. Merck Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Pfizer Nanopharmaceuticals Product
Table 89. Pfizer Recent Development
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Novartis Nanopharmaceuticals Product
Table 94. Novartis Recent Development
Table 95. Abbott Corporation Information
Table 96. Abbott Description and Business Overview
Table 97. Abbott Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Abbott Nanopharmaceuticals Product
Table 99. Abbott Recent Development
Table 100. GlaxoSmithKline Corporation Information
Table 101. GlaxoSmithKline Description and Business Overview
Table 102. GlaxoSmithKline Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. GlaxoSmithKline Nanopharmaceuticals Product
Table 104. GlaxoSmithKline Recent Development
Table 105. Roche Corporation Information
Table 106. Roche Description and Business Overview
Table 107. Roche Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Roche Nanopharmaceuticals Product
Table 109. Roche Recent Development
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Sanofi Nanopharmaceuticals Product
Table 114. Sanofi Recent Development
Table 115. Eli Lilly Corporation Information
Table 116. Eli Lilly Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Eli Lilly Description and Business Overview
Table 118. Eli Lilly Nanopharmaceuticals Product
Table 119. Eli Lilly Recent Development
Table 120. Astrazeneca Corporation Information
Table 121. Astrazeneca Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Astrazeneca Description and Business Overview
Table 123. Astrazeneca Nanopharmaceuticals Product
Table 124. Astrazeneca Recent Development
Table 125. Johnson & Johnson Corporation Information
Table 126. Johnson & Johnson Description and Business Overview
Table 127. Johnson & Johnson Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Johnson & Johnson Nanopharmaceuticals Product
Table 129. Johnson & Johnson Recent Development
Table 130. Celgene Corporation Information
Table 131. Celgene Description and Business Overview
Table 132. Celgene Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Celgene Nanopharmaceuticals Product
Table 134. Celgene Recent Development
Table 135. Novavax Corporation Information
Table 136. Novavax Description and Business Overview
Table 137. Novavax Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Novavax Nanopharmaceuticals Product
Table 139. Novavax Recent Development
Table 140. Stryker Corporation Information
Table 141. Stryker Description and Business Overview
Table 142. Stryker Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Stryker Nanopharmaceuticals Product
Table 144. Stryker Recent Development
Table 145. Gilead Sciences Corporation Information
Table 146. Gilead Sciences Description and Business Overview
Table 147. Gilead Sciences Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Gilead Sciences Nanopharmaceuticals Product
Table 149. Gilead Sciences Recent Development
Table 150. OSI Pharmaceuticals Corporation Information
Table 151. OSI Pharmaceuticals Description and Business Overview
Table 152. OSI Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. OSI Pharmaceuticals Nanopharmaceuticals Product
Table 154. OSI Pharmaceuticals Recent Development
Table 155. Kadmon Pharmaceuticals Corporation Information
Table 156. Kadmon Pharmaceuticals Description and Business Overview
Table 157. Kadmon Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Kadmon Pharmaceuticals Nanopharmaceuticals Product
Table 159. Kadmon Pharmaceuticals Recent Development
Table 160. Samyang Biopharm Corporation Information
Table 161. Samyang Biopharm Description and Business Overview
Table 162. Samyang Biopharm Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 163. Samyang Biopharm Nanopharmaceuticals Product
Table 164. Samyang Biopharm Recent Development
Table 165. Mitsubishi Pharma Corporation Information
Table 166. Mitsubishi Pharma Description and Business Overview
Table 167. Mitsubishi Pharma Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 168. Mitsubishi Pharma Nanopharmaceuticals Product
Table 169. Mitsubishi Pharma Recent Development
Table 170. Kaken Pharmaceutical Corporation Information
Table 171. Kaken Pharmaceutical Description and Business Overview
Table 172. Kaken Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 173. Kaken Pharmaceutical Nanopharmaceuticals Product
Table 174. Kaken Pharmaceutical Recent Development
Table 175. Selecta Biosciences Corporation Information
Table 176. Selecta Biosciences Description and Business Overview
Table 177. Selecta Biosciences Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 178. Selecta Biosciences Nanopharmaceuticals Product
Table 179. Selecta Biosciences Recent Development
Table 180. Par Pharmaceutical Corporation Information
Table 181. Par Pharmaceutical Description and Business Overview
Table 182. Par Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 183. Par Pharmaceutical Nanopharmaceuticals Product
Table 184. Par Pharmaceutical Recent Development
Table 185. Cerulean Pharma Corporation Information
Table 186. Cerulean Pharma Description and Business Overview
Table 187. Cerulean Pharma Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 188. Cerulean Pharma Nanopharmaceuticals Product
Table 189. Cerulean Pharma Recent Development
Table 190. Navidea Biopharmaceuticals Corporation Information
Table 191. Navidea Biopharmaceuticals Description and Business Overview
Table 192. Navidea Biopharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 193. Navidea Biopharmaceuticals Nanopharmaceuticals Product
Table 194. Navidea Biopharmaceuticals Recent Development
Table . Lummy Corporation Information
Table . Lummy Description and Business Overview
Table . Lummy Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . Lummy Nanopharmaceuticals Product
Table . Lummy Recent Development
Table 200. Production Base and Market Concentration Rate of Raw Material
Table 201. Key Suppliers of Raw Materials
Table 202. Nanopharmaceuticals Distributors List
Table 203. Nanopharmaceuticals Customers List
Table 204. Market Key Trends
Table 205. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 206. Key Challenges
Table 207. Research Programs/Design for This Report
Table 208. Key Data Information from Secondary Sources
Table 209. Key Data Information from Primary Sources
List of Figures
Figure 1. Nanopharmaceuticals Product Picture
Figure 2. Global Nanopharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Nanopharmaceuticals Market Share by Application in 2020 & 2026
Figure 6. Cancer and Tumor Examples
Figure 7. Autoimmune Disorders Examples
Figure 8. Inflammation Examples
Figure 9. Others Examples
Figure 10. Global Nanopharmaceuticals Sales (K MT) Growth Rate (2015-2026)
Figure 11. Global Nanopharmaceuticals Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Nanopharmaceuticals Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Nanopharmaceuticals Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Nanopharmaceuticals Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Nanopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Nanopharmaceuticals Sales (K MT) Growth Rate (2015-2026)
Figure 17. Europe Nanopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Nanopharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Nanopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Nanopharmaceuticals Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Nanopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Nanopharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Nanopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Nanopharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Nanopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Nanopharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Nanopharmaceuticals Players Market Share by Revenue in Nanopharmaceuticals 2015 & 2019
Figure 28. Nanopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Nanopharmaceuticals Revenue Share by Type (2015-2020)
Figure 30. Global Nanopharmaceuticals Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Nanopharmaceuticals Revenue Share by Application (2015-2020)
Figure 32. Global Nanopharmaceuticals Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Nanopharmaceuticals Sales Market Share by Type in 2019
Figure 34. United States Nanopharmaceuticals Sales Market Share by Type in 2019
Figure 35. Europe Nanopharmaceuticals Sales Market Share by Company in 2019
Figure 36. Europe Nanopharmaceuticals Sales Market Share by Type in 2019
Figure 37. Europe Nanopharmaceuticals Sales Market Share by Application in 2019
Figure 38. China Nanopharmaceuticals Sales Market Share by Company in 2019
Figure 39. China Nanopharmaceuticals Sales Market Share by Type in 2019
Figure 40. China Nanopharmaceuticals Sales Market Share by Application in 2019
Figure 41. Japan Nanopharmaceuticals Sales Market Share by Company in 2019
Figure 42. Japan Nanopharmaceuticals Sales Market Share by Type in 2019
Figure 43. Japan Nanopharmaceuticals Sales Market Share by Application in 2019
Figure 44. Southeast Asia Nanopharmaceuticals Sales Market Share by Company in 2019
Figure 45. Southeast Asia Nanopharmaceuticals Sales Market Share by Type in 2019
Figure 46. Southeast Asia Nanopharmaceuticals Sales Market Share by Application in 2019
Figure 47. India Nanopharmaceuticals Sales Market Share by Company in 2019
Figure 48. India Nanopharmaceuticals Sales Market Share by Type in 2019
Figure 49. India Nanopharmaceuticals Sales Market Share by Application in 2019
Figure 50. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Novavax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Stryker Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. OSI Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Kadmon Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Samyang Biopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Mitsubishi Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Kaken Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Selecta Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Par Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Cerulean Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 72. Navidea Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 73. Lummy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 74. Key Raw Materials Price Trend
Figure 75. Manufacturing Cost Structure of Nanopharmaceuticals
Figure 76. Manufacturing Process Analysis of Nanopharmaceuticals
Figure 77. Nanopharmaceuticals Industrial Chain Analysis
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Porter's Five Forces Analysis
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
ナノ医薬品の世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Nanopharmaceuticals market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 12.4% in the forecast period of 2020 to 2025 and will expected to reach USD 39510 million by 2025, from USD 24720 million in 2019. The Nanopharm…- ナノドラッグの世界市場レポート2020 Market Analysis and Insights: Global Nano-drug Market The global Nano-drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Nano-drug Scope and Market Size The global Nano-drug market is segmented by Type,…
- 固形腫瘍治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Solid Tumor Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.1% in the forecast period of 2020 to 2025 and will expected to reach USD 156810 million by 2025, from USD 114670 million in 2019. The Solid Tumor…
- 樹状細胞および腫瘍細胞がんワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also stati…
- ナノ粒子の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Nanoparticles market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nanoparticles market report pro…